View Item 

Show simple item record

Comparison of retinal vasodilator and constrictor responses in type 2 diabetes

dc.contributor.authorLott, Mary E. J.en_US
dc.contributor.authorSlocomb, Julia E.en_US
dc.contributor.authorShivkumar, Vikramen_US
dc.contributor.authorSmith, Bruceen_US
dc.contributor.authorGabbay, Robert A.en_US
dc.contributor.authorQuillen, Daviden_US
dc.contributor.authorGardner, Thomas W.en_US
dc.contributor.authorBettermann, Kerstinen_US
dc.date.accessioned2012-09-05T14:46:10Z
dc.date.available2013-10-18T17:47:29Zen_US
dc.date.issued2012-09en_US
dc.identifier.citationLott, Mary E. J.; Slocomb, Julia E.; Shivkumar, Vikram; Smith, Bruce; Gabbay, Robert A.; Quillen, David; Gardner, Thomas W.; Bettermann, Kerstin (2012). "Comparison of retinal vasodilator and constrictor responses in type 2 diabetes." Acta Ophthalmologica 90(6): e434-e441. <http://hdl.handle.net/2027.42/93551>en_US
dc.identifier.issn1755-375Xen_US
dc.identifier.issn1755-3768en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/93551
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherRetinal Reactivityen_US
dc.subject.otherHyperoxiaen_US
dc.subject.otherDiabetesen_US
dc.subject.otherVasodilationen_US
dc.subject.otherVasoconstrictionen_US
dc.subject.otherFlickering‐Induced Vasodilationen_US
dc.titleComparison of retinal vasodilator and constrictor responses in type 2 diabetesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumKellogg Eye Center, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Ophthalmology, Penn State Hershey Medical Center, Hershey, PA, USAen_US
dc.contributor.affiliationotherPenn State Institute for Diabetes and Obesity, Penn State College of Medicine, Division of Endocrinology, Diabetes and Metabolism, Hershey, PA, USAen_US
dc.contributor.affiliationotherDepartment of Neurology, Penn State Hershey Medical Center, Hershey, PA, USAen_US
dc.contributor.affiliationotherPenn State Hershey Medical Center, Heart and Vascular Institute, Hershey, PA, USAen_US
dc.identifier.pmid22682034en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/93551/1/j.1755-3768.2012.02445.x.pdf
dc.identifier.doi10.1111/j.1755-3768.2012.02445.xen_US
dc.identifier.sourceActa Ophthalmologicaen_US
dc.identifier.citedreferenceNagaoka T, Hein TW, Yoshida A & Kuo L ( 2007 ): Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate‐rho kinase pathways. Invest Ophthalmol Vis Sci 48: 825 – 832.en_US
dc.identifier.citedreferenceGrunwald JE, DuPont J & Riva CE ( 1996 ): Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 80: 327 – 331.en_US
dc.identifier.citedreferenceHiggins RD, Hendricks‐Munoz KD, Caines VV, Gerrets RP & Rifkin DB ( 1998 ): Hyperoxia stimulates endothelin‐1 secretion from endothelial cells; modulation by captopril and nifedipine. Curr Eye Res 17: 487 – 493.en_US
dc.identifier.citedreferenceIzumi N, Nagaoka T, Mori F, Sato E, Takahashi A & Yoshida A ( 2006 ): Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol 50: 465 – 468.en_US
dc.identifier.citedreferenceJean‐Louis S, Lovasik JV & Kergoat H ( 2005 ): Systemic hyperoxia and retinal vasomotor responses. Invest Ophthalmol Vis Sci 46: 1714 – 1720.en_US
dc.identifier.citedreferenceJustesen BL, Mistry P, Chaturvedi N, Thom SA, Witt N, Kohler D, Hughes AD & Sjolie AK ( 2010 ): Retinal arterioles have impaired reactivity to hyperoxia in type 1 diabetes. Acta Ophthalmol 88: 453 – 457.en_US
dc.identifier.citedreferenceKawamura H, Oku H, Li Q, Sakagami K & Puro DG ( 2002 ): Endothelin‐induced changes in the physiology of retinal pericytes. Invest Ophthalmol Vis Sci 43: 882 – 888.en_US
dc.identifier.citedreferenceKim JA, Montagnani M, Koh KK & Quon MJ ( 2006 ): Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888 – 1904.en_US
dc.identifier.citedreferenceKiss B, Polska E, Dorner G et al. ( 2002 ): Retinal blood flow during hyperoxia in humans revisited: concerted results using different measurement techniques. Microvasc Res 64: 75 – 85.en_US
dc.identifier.citedreferenceKohner EM, Patel V & Rassam SM ( 1995 ): Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603 – 607.en_US
dc.identifier.citedreferenceKondo M, Wang L & Bill A ( 1997 ): The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand 75: 232 – 235.en_US
dc.identifier.citedreferenceMaejima K, Nakano S, Himeno M et al. ( 2001 ): Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications 15: 135 – 143.en_US
dc.identifier.citedreferenceMak S, Egri Z, Tanna G, Colman R & Newton GE ( 2002 ): Vitamin C prevents hyperoxia‐mediated vasoconstriction and impairment of endothelium‐dependent vasodilation. Am J Physiol Heart Circ Physiol 282: H2414 – H2421.en_US
dc.identifier.citedreferenceMandecka A, Dawczynski J, Blum M et al. ( 2007 ): Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30: 3048 – 3052.en_US
dc.identifier.citedreferenceMcNulty PH, Robertson BJ, Tulli MA, Hess J, Harach LA, Scott S & Sinoway LI ( 2007 ): Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol 102: 2040 – 2045.en_US
dc.identifier.citedreferenceMichelson G, Patzelt A & Harazny J ( 2002 ): Flickering light increases retinal blood flow. Retina 22: 336 – 343.en_US
dc.identifier.citedreferenceNagel E, Vilser W & Lanzl I ( 2004 ): Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci 45: 1486 – 1492.en_US
dc.identifier.citedreferenceNguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W & Wong TY ( 2009 ): Flicker light‐induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32: 2075 – 2080.en_US
dc.identifier.citedreferenceOzden S, Tatlipinar S, Bicer N, Yaylali V, Yildirim C, Ozbay D & Guner G ( 2003 ): Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol 38: 393 – 396.en_US
dc.identifier.citedreferencePatton N, Aslam TM, MacGillivray T, Deary IJ, Dhillon B, Eikelboom RH, Yogesan K & Constable IJ ( 2006 ): Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res 25: 99 – 127.en_US
dc.identifier.citedreferencePemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M & Schmetterer L ( 2009 ): Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci 50: 4029 – 4032.en_US
dc.identifier.citedreferencePournaras CJ, Rungger‐Brandle E, Riva CE, Hardarson SH & Stefansson E ( 2008 ): Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27: 284 – 330.en_US
dc.identifier.citedreferenceRiva CE, Grunwald JE & Sinclair SH ( 1983 ): Laser Doppler Velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci 24: 47 – 51.en_US
dc.identifier.citedreferenceRubanyi GM & Vanhoutte PM ( 1986 ): Superoxide anions and hyperoxia inactivate endothelium‐derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822 – H827.en_US
dc.identifier.citedreferenceSchmetterer L & Wolzt M ( 1999 ): Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42: 387 – 405.en_US
dc.identifier.citedreferenceSchmetterer L, Findl O, Fasching P et al. ( 1997 ): Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 46: 653 – 658.en_US
dc.identifier.citedreferenceSkov Jensen P, Jeppesen P & Bek T ( 2011 ): Differential diameter responses in macular and peripheral retinal arterioles may contribute to the regional distribution of diabetic retinopathy lesions. Graefes Arch Clin Exp Ophthalmol 249: 407 – 412.en_US
dc.identifier.citedreferenceTakagi C, King GL, Takagi H, Lin YW, Clermont AC & Bursell SE ( 1996 ): Endothelin‐1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Invest Ophthalmol Vis Sci 37: 2099 – 2109.en_US
dc.identifier.citedreferenceToda N & Nakanishi‐Toda M ( 2007 ): Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 26: 205 – 238.en_US
dc.identifier.citedreferenceYu DY, Su EN, Cringle SJ, Schoch C, Percicot CP & Lambrou GN ( 2001 ): Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci 42: 1499 – 1504.en_US
dc.identifier.citedreferenceZhilyaev SY, Moskvin AN, Platonova TF, Gutsaeva DR, Churilina IV & Demchenko IT ( 2003 ): Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions. Neurosci Behav Physiol 33: 783 – 787.en_US
dc.identifier.citedreferenceZhu Y, Park TS & Gidday JM ( 1998 ): Mechanisms of hyperoxia‐induced reductions in retinal blood flow in newborn pig. Exp Eye Res 67: 357 – 369.en_US
dc.identifier.citedreferenceAnand‐Apte B & Hollyfield JG ( 2011 ): Development anatomy of the retinal and choroidal vasculature. In: Besharse JC & Bok D (eds.). The retina and its disorders. San Diego, CA, USA: Academic Press (Elsevier Ltd ): 179 – 194.en_US
dc.identifier.citedreferenceBek T, Hajari J & Jeppesen P ( 2008 ): Interaction between flicker‐induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 246: 763 – 769.en_US
dc.identifier.citedreferenceBellia A, Rizza S, Galli A, Fabiano R, Donadel G, Lombardo MF, Cardillo C, Sbraccia P, Tesauro M & Lauro D ( 2010 ): Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis 210: 199 – 201.en_US
dc.identifier.citedreferenceBuerk DG, Riva CE & Cranstoun SD ( 1995 ): Frequency and luminance‐dependent blood flow and K+ ion changes during flicker stimuli in cat optic nerve head. Invest Ophthalmol Vis Sci 36: 2216 – 2227.en_US
dc.identifier.citedreferenceBuerk DG, Riva CE & Cranstoun SD ( 1996 ): Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res 52: 13 – 26.en_US
dc.identifier.citedreferenceCheung N, Islam FM, Jacobs DR Jr et al. ( 2007 ): Arterial compliance and retinal vascular caliber in cerebrovascular disease. Ann Neurol 62: 618 – 624.en_US
dc.identifier.citedreferenceDallinger S, Dorner GT, Wenzel R, Graselli U, Findl O, Eichler HG, Wolzt M & Schmetterer L ( 2000 ): Endothelin‐1 contributes to hyperoxia‐induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci 41: 864 – 869.en_US
dc.identifier.citedreferenceDorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE & Schmetterer L ( 2003 ): Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 285: H631 – H636.en_US
dc.identifier.citedreferenceFormaz F, Riva CE & Geiser M ( 1997 ): Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res 16: 1252 – 1257.en_US
dc.identifier.citedreferenceGarhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L & Dorner GT ( 2004 ): Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88: 887 – 891.en_US
dc.identifier.citedreferenceGarhofer G, Bek T, Boehm AG et al. ( 2010 ): Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmol 88: 717 – 722.en_US
dc.identifier.citedreferenceGhosh A, Sherpa ML, Bhutia Y, Pal R & Dahal S ( 2011 ): Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. Int J App Basic Med Res 1: 31 – 35.en_US
dc.identifier.citedreferenceGilmore ED, Hudson C, Preiss D & Fisher J ( 2005 ): Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation. Am J Physiol Heart Circ Physiol 288: H2912 – H2917.en_US
dc.identifier.citedreferenceGilmore ED, Hudson C, Nrusimhadevara RK, Harvey PT, Mandelcorn M, Lam WC & Devenyi RG ( 2007 ): Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight‐threatening diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 1744 – 1750.en_US
dc.identifier.citedreferenceGrunwald JE, Riva CE, Petrig BL, Sinclair SH & Brucker AJ ( 1984 ): Effect of pure O2‐breathing on retinal blood flow in normals and in patients with background diabetic retinopathy. Curr Eye Res 3: 239 – 241.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1755-3768.2012.02445.x.pdf
Size:
356.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.